http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104414978-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104414978-B |
| titleOfInvention | A kind of enteric-coated micro-pill containing esomeprazole magnesium |
| abstract | The present invention relates to a kind of enteric-coated micro-pill containing esomeprazole magnesium, comprising inertia capsule core, drug-loaded layer, separation layer and enteric layer, contain methacrylic acid/ethyl acrylate 1 in enteric layer:1 copolymer, glycerin monostearate, Tween 80 and talcum powder, wherein methacrylic acid/ethyl acrylate 1:1 copolymer is preferably Eudragit L30D 55.The esomeprazole enteric capsules that the present invention is provided, acid-resistant strength, release and the stability of product can be taken into account for a long time in placement process, disclosure satisfy that or better than existing preparation quality standard, and process is simple, it is adaptable to larger capsule core（0.3mm~1mm）, be more suitable for large-scale industrial production the characteristics of low with production cost. |
| priorityDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.